News Highlights: Top Company News of the Day - Friday at 3 PM ET

Nike Investors Glad Donahoe Is Out, but Hill Has Long Road Ahead 
 

After losing market share in recent years, Nike faces near-term challenges such as the sales momentum among competitors.

 
FTC Accuses Drug Middlemen of Inflating Insulin Prices 
 

The Federal Trade Commission sued the drug middlemen that health plans use to keep a lid on drug spending, accusing the firms of inflating the price of insulin.

 
Three Mile Island's Nuclear Plant to Reopen, Help Power Microsoft's AI Centers 
 

The 20-year deal with Constellation Energy would kick-start the site of the nation's worst nuclear power accident.

 
Germany to Keep Commerzbank Shares After UniCredit Takes Stake 
 

The government said it won't offload any additional shares in the bank following the sale to UniCredit for EUR702 million. The move marks an U-turn for the government.

 
FedEx's earnings miss may be more of a speed bump than a brick wall, analyst says 
 

Analysts see a potential spinoff of FedEx's freight business as a possible boost, but the stock is dropping sharply

 
Peloton's Comeback Marketing Plan: Less Bike, Fewer Promotions, More Men 
 

Peloton's chief marketing officer has a strategy to get the beleaguered fitness company back on track: Don't talk only about the bike.

 
New York Magazine Puts Olivia Nuzzi on Leave Over RFK Jr. Relationship 
 

The magazine placed political journalist Olivia Nuzzi on leave after she disclosed a romantic relationship with former presidential candidate Robert F. Kennedy Jr.

 
Nokia Says German Court Ruled in its Favor Over Amazon Patent Dispute 
 

Nokia had claimed the unauthorized use of its video-related technologies in streaming services and devices by Amazon.

 
The Price War in Weight-Loss Drugs Is Here 
 

Novo Nordisk and Eli Lilly are offering discounts to encourage more insurance coverage of the medicines, which carry price tags of over $1,000 a month.

 
Novo Nordisk's Wegovy Gets EU Backing to Treat Heart Conditions 
 

Novo Nordisk said European regulators support the use of its blockbuster weight-loss drug Wegovy to help reduce heart failure in obese patients.

(END) Dow Jones Newswires

September 20, 2024 15:15 ET (19:15 GMT)

Copyright (c) 2024 Dow Jones & Company, Inc.